Lee Ainslie’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$48.6M Buy
+538,008
New +$31.5M 0.38% 42
2021
Q3
– Sell
-822
Closed -$161K – 803
2021
Q2
$161K Sell
822
-1,180
-59% -$214K ﹤0.01% 515
2021
Q1
$362K Buy
2,002
+623
+45% +$108K ﹤0.01% 410
2020
Q4
$195K Buy
+1,379
New +$200K ﹤0.01% 529

Other funds holding TXG

Lee Ainslie's TXG Position: Q3 2026 in Review

Lee Ainslie opened a new position in 10x Genomics (TXG) in Q3 2026: 538,008 shares worth $48.6M. The stake represents 0.38% of the portfolio and ranks #42 among its holdings. This is a return to the name: Lee Ainslie previously reported a position in TXG as recently as Q2 2021.

Lee Ainslie first reported a position in TXG in Q4 2020 and has held it in 4 quarters since. 488 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Lee Ainslie held 538,008 shares of 10x Genomics worth $48.6M as of Q3 2026.
  • 10x Genomics was a new Lee Ainslie position in Q3 2026.
  • 10x Genomics made up 0.38% of Lee Ainslie's portfolio in Q3 2026, its #42 holding.
  • Lee Ainslie first reported a position in 10x Genomics in Q4 2020 and has held it in 4 quarters since.
  • 488 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Maverick Capital's 13F filing for Q3 2026, filed 16 Nov 2026.